Outcomes11

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 11 of 11

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Overall Response Rate	2 years	All eligible patients that had a disease evaluation after being treated.	proportion of participants	NUMBER
SECONDARY	Duration of Response	2 years	All eligible and treated patients that achieve a response.	years	MEDIAN
SECONDARY	Overall Survival	37 months	All eligible and treated patients.	Months	MEDIAN
SECONDARY	Progression Free Survival (PFS)	37 months	All eligible and treated patients that had a disease evaluation.	Months	MEAN
SECONDARY	Proportion of Patients With Grade 3 or Higher Adverse Events	25 months	All eligible and treated patients.	proportion of patients	NUMBER
OTHER_PRE_SPECIFIED	Change in CD27 Expression in Tissue	Baseline up to 100 days after last dose of study drug
OTHER_PRE_SPECIFIED	Change in Peripheral Blood Immune Cells	Baseline up to 12 weeks
OTHER_PRE_SPECIFIED	Change in the Identification/Characterization of Intratumoral Immune Cells in Tissue	Baseline up to time of disease progression
OTHER_PRE_SPECIFIED	Change in Genetic Alterations of Chromosome 9p24.1 in Tissue	Baseline up to time of disease progression
OTHER_PRE_SPECIFIED	Change in Serum Cytokine Profile	Baseline up to 12 weeks
OTHER_PRE_SPECIFIED	Change in Mutation Burden in Tissue	Baseline up to time of disease progression

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03038672/outcomes